Suven Life Sciences Limited (SUVEN.NS)
INR 142.78
(-0.61%)
INR 142.78
(-0.61%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 116.92 Million | 135.39 Million | 118.44 Million | 134.78 Million | 144.14 Million | 6.45 Billion |
| Cost of Revenue | 317.72 Million | 5.65 Million | 24.32 Million | 1.03 Million | 227 Thousand | 2.73 Billion |
| Gross Profit | -200.79 Million | 129.73 Million | 94.11 Million | 133.75 Million | 143.92 Million | 3.72 Billion |
| Operating Expenses | 109.75 Million | 1.45 Billion | 1.37 Billion | 966.43 Million | 1.33 Billion | 2.33 Billion |
| Selling, General and Administrative Expenses | 27.1 Million | 25.34 Million | 24.94 Million | 22.87 Million | 9.75 Million | 205.49 Million |
| Research and Development Expenses | 1.14 Billion | 1.15 Billion | 1.06 Billion | 710.27 Million | 1.03 Billion | 1.08 Billion |
| Other Expenses | - | 84.49 Million | 130 Thousand | 77.53 Million | 296.92 Million | 3.3 Million |
| Cost and Expenses | 1.34 Billion | 1.45 Billion | 1.37 Billion | 966.43 Million | 1.33 Billion | 5.06 Billion |
| Operating Income | -1.22 Billion | -1.31 Billion | -1.26 Billion | -832.84 Million | -1.19 Billion | 1.38 Billion |
| Interest Expense | 2.98 Million | 2.89 Million | 5.32 Million | 8.15 Million | 4.87 Million | 19.9 Million |
| Income Tax Expense | -10.02 Million | 86.53 Million | 15.97 Million | -53.22 Million | -121.82 Million | 718 Million |
| Earnings before Tax | -1.06 Billion | -1.18 Billion | -1.21 Billion | -774.74 Million | -1.06 Billion | 1.58 Billion |
| Net Income | -1.05 Billion | -1.18 Billion | -1.21 Billion | -721.51 Million | -942.17 Million | 869.43 Million |
| Earnings Per Share Basic | -4.82 | -7.50 | -7.73 | -4.57 | -5.97 | 5.51 |
| Earnings Per Share Diluted | -4.82 | -7.47 | -7.71 | -4.56 | -5.95 | 5.50 |
| Weighted Average Shares Outstanding | 218 Million | 157.77 Million | 157.77 Million | 157.77 Million | 157.77 Million | 157.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 218.07 Million | 158.22 Million | 158.22 Million | 158.22 Million | 158.22 Million | 158.22 Million |
| Gross Margin | -1.72 | 0.96 | 0.79 | 0.99 | 1.00 | 0.58 |
| EBIT Margin | -8.49 | -8.67 | -10.22 | -5.37 | -7.09 | 0.26 |
| Profit Margin | -8.99 | -8.74 | -10.30 | -5.35 | -6.54 | 0.13 |
| EBITDA | -992.78 Million | -1.11 Billion | -1.16 Billion | -721.87 Million | -1.01 Billion | 162.66 Million |
| Earnings Before Tax Margin | -10.48 | -9.74 | -10.66 | -6.18 | -8.29 | 0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 25.72 Million | 10.06 Million | 23.85 Million | 116.92 Million | 24.5 Million | 30.59 Million |
| Cost of Revenue | 86.51 Million | 81.12 Million | 66.59 Million | 317.72 Million | 86.24 Million | 77.98 Million |
| Gross Profit | -60.78 Million | -71.06 Million | -42.74 Million | -200.79 Million | -61.73 Million | -47.39 Million |
| Operating Expenses | 562.36 Million | 249.18 Million | 275.21 Million | 1.14 Billion | 502.45 Million | 282.96 Million |
| Selling, General and Administrative Expenses | - | 46.89 Million | 34.64 Million | - | 57.93 Million | 44.48 Million |
| Research and Development Expenses | 475.84 Million | 249.18 Million | 275.21 Million | - | 416.21 Million | 204.97 Million |
| Other Expenses | 86.51 Million | 40.08 Million | 42.83 Million | 211.3 Million | 60.65 Million | 51.41 Million |
| Cost and Expenses | 562.36 Million | 330.3 Million | 341.81 Million | 1.46 Billion | 502.45 Million | 282.96 Million |
| Operating Income | -536.63 Million | -320.24 Million | -317.96 Million | -1.34 Billion | -417.29 Million | -200.94 Million |
| Interest Expense | 156 Thousand | 231 Thousand | 299 Thousand | 1.58 Million | 354 Thousand | 419 Thousand |
| Income Tax Expense | 40.35 Million | - | -10.02 Million | -10.02 Million | 16.06 Million | 17.14 Million |
| Earnings before Tax | -496.43 Million | -280.39 Million | -275.43 Million | -1.06 Billion | -417.64 Million | -126.8 Million |
| Net Income | -496.43 Million | -280.39 Million | -265.4 Million | -1.05 Billion | -417.64 Million | -126.8 Million |
| Earnings Per Share Basic | -2.27 | -1.29 | -1.68 | - | -2.65 | -0.80 |
| Earnings Per Share Diluted | -2.27 | -1.29 | -1.68 | - | -2.64 | -0.80 |
| Weighted Average Shares Outstanding | 218.69 Million | 218.07 Million | 157.77 Million | 157.77 Million | 157.77 Million | 157.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 218.69 Million | 218.07 Million | 158.22 Million | 158.22 Million | 158.22 Million | 158.22 Million |
| Gross Margin | -2.36 | -7.06 | -1.79 | -1.72 | -2.52 | -1.55 |
| EBIT Margin | -18.72 | -30.36 | -12.70 | - | -16.37 | -6.00 |
| Profit Margin | -19.29 | -27.87 | -11.13 | -8.99 | -17.04 | -4.14 |
| EBITDA | -481.73 Million | -305.38 Million | -302.87 Million | - | -401.26 Million | -183.68 Million |
| Earnings Before Tax Margin | -20.86 | -31.83 | -13.33 | -11.50 | -17.03 | -6.57 |
EKTAF
002658
SKFINDIA
PNV
0AAW
MGA